Clinical Practice Guidelines Committee at Work

The UHMS CPG Oversight Committee, chaired by Dr. Enoch Huang, has completed work on the first clinical practice guideline for the UHMS: ‘A clinical practice guideline for the use of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers.’ The paper is available here: https://www.uhms.org/cpg.

Continue Reading

Safety Time Out/Pause - "Stop"

UHMS Position Statement 
Safety Timeout and Pause “STOP” 

The Safety Committee of the Undersea and Hyperbaric Medical Society recommends that a Safety Time Out / Pause (STOP) be performed prior to the start of every hyperbaric treatment. A STOP should be completed regardless of multiplace or monoplace operations. A STOP will be performed in order to be compliant with safety goals, to combat complacency, and document completion of our unique safety practices. We recommend that the STOP be modeled after the timeouts performed before surgical procedures. 

Continue Reading

UHMS Credentialing and Privileging Guidelines for Hyperbaric Medicine Physicians in the U.S.A.

UHMS Credentialing and Privileging Guidelines For Hyperbaric Medicine Physicians in the U.S.A. 
Revised: 26 June 2014 
 
 
Principles Intrinsic to Ensuring Patient Access to Safe, High‐Quality Hyperbaric Oxygen (HBO2) Therapy HBO2 therapy entails medical risks and should be provided only by physicians with specialized training in hyperbaric medicine and facilities properly equipped and maintained to do so.  For physicians, experience in both routine and emergent HBO2 treatment situations is expected.  For facilities, formal accreditation through a facility accreditation program recognized by the Joint Commission, such as the UHMS accreditation program, is recommended.  A 5‐year transition period is recommended to enable all hyperbaric medicine physicians and facilities to meet these certification, privileging and accreditation guidelines.  However, during this transition period, patient access to HBO2 therapy for approved indications should not be limited. 

Continue Reading

A Letter from UHMS President, Dr. John Feldmeier in Response to The recent article by Margolis

A Letter from UHMS President, Dr. John Feldmeier in Response to The recent article by Margolis et al that reports the failure of hyperbaric oxygen in the treatment of diabetic foot ulcers. 
Click Here for full Letter

Interpretation of the study "Lack of Effectiveness of Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcer and Prevention of Amputation"

Interpretation of the study "Lack of Effectiveness of Hyperbaric Oxygen Therapy for the Treatment of Diabetic Foot Ulcer and Prevention of Amputation"
Submitted by UHMS Member, Dr. Phi-Nga Jeannie Le et al.
Full paper to be printed in the Undersea and Hyperbaric Medicine Journal.
(On behalf of the UHMS Quality, Utilization, Authorization, Reimbursement Committee)

UHMS/CDC Carbon Monoxide Surveillance Project

NOW COMPLETE

Neil B. Hampson, MD

After 3 years of operation, the joint project between the UHMS and the US Centers for Disease Control and Prevention (CDC) to conduct online surveillance of cases of carbon monoxide (CO) poisoning treated with hyperbaric oxygen was completed in December 2011. Due to cutbacks in Federal funding for the CDC, financial support was not available for a fourth year. Furthermore, the pilot project had already achieved all of the goals established when it went online in August 2008, and more.

Continue Reading

  • 1
  • 2